MAMA · Mama's Creations, Inc. · Stock research

# MAMA — Mama's Creations, Inc.

Current Thesis

The level that prior coverage named as the structural floor is gone. The 2026-08-21 weekly close was $16.44 — under the $16.50 shelf, under the $18.00 price at which the company itself placed 5,555,556 shares on 2026-06-30, and 20.4% below the 52-week high of $20.65. RSI(14) at 26.3 into that close is the most stretched-to-the-downside reading of the covered period, and the stock rose 2.81% on 2026-08-21 off it. Nothing in the operating record changed to produce the fade: the last reported quarter (Q1 FY2027, 2026-06-08) put revenue at $52.8M, +49.7% YoY, adjusted EBITDA at $4.9M, +71.2%, and EPS at $0.05 against $0.03 consensus, and no analyst has published a rating change through 2026-08-21. What did change is the clock. A 2026-08-20 release fixed Q2 FY2027 results for after the close on 2026-09-03, with a 4:30 p.m. ET call — earlier than the ~2026-09-08 date this note had carried from the year-ago analogue. The narrative leg on offer is unchanged in content and worse in position: a $189.23M-TTM-revenue deli platform converting ~$94.0M of net new cash into Crown-style bolt-ons while gross margin climbs off 23.6%. Both halves resolve, or fail to, on 2026-09-03.

Bullish and bearish views on Mama's Creations, Inc.

The model's bull view on Mama's Creations, Inc. (MAMA), in brief: Q1 FY2027 (2026-06-08): revenue $52.8M, +49.7% YoY from $35.3M; adjusted EBITDA $4.9M, +71.2%; EPS $0.05 vs $0.03 consensus. The bear view: Price is below the level the company chose to sell stock at. Both cases follow in full.

Bull Case

• Q1 FY2027 (2026-06-08): revenue $52.8M, +49.7% YoY from $35.3M; adjusted EBITDA $4.9M, +71.2%; EPS $0.05 vs $0.03 consensus. TTM revenue stood at $189.23M, +47.0%, as of 2026-08-21.
• The acquisition budget is funded and sized: $24.4M cash against $5.1M debt at Q1 FY2027, plus roughly $94.0M net from the 2026-06-30 offering. Crown I cost $17.5M cash for a business carrying about $56M of revenue and closed 2025-09-02 — that transaction is the stated price template, and the current cash line buys several of them without returning to the market.
• Sell-side attention has not reversed with price: 8 analysts, all Buy, average target $22.43, low $20 (Lake Street, 2026-06-09), high $25 (D.A. Davidson reiteration 2026-07-10; Benchmark initiation 2026-07-22). MEASURED: no rating or target change was published in August 2026 through 2026-08-21. INFERRED: the drawdown is therefore flow and positioning rather than a visible estimate cut.
• Management's margin bridge is explicit and dated: the 23.6% Q1 gross margin was attributed on the 2026-06-08 call to new packaging-technology startup costs, with a mid-to-high-20s% target reiterated.
• The print arriving 2026-09-03 rather than ~2026-09-08 shortens the window in which an oversold tape has to carry itself with no company news.

Bear Case

• Price is below the level the company chose to sell stock at. The 2026-06-30 placement was struck at $18.00 when the prior close (2026-06-26) was $19.94; the 2026-08-21 close of $16.44 sits beneath both, seven weeks later.
• Dilution is booked, accretion is not. Shares outstanding were 46.50M as of 2026-08-21 against a pre-deal count near 40.7M, for a market value of $764.42M. No acquisition has been announced publicly between the 2026-06-30 pricing and 2026-08-21, so the proceeds have earned cash-rate returns for two months against a permanently larger denominator.
• Gross margin was 23.6% in Q1 FY2027 versus 26.1% a year earlier. The transient-cost explanation has been untested for a full quarter and gets its first check on 2026-09-03.
• The quarter reported on 2026-09-03 (ended 2026-07-31) is the last one carrying an un-lapped Crown contribution; the lap begins with the fiscal quarter that started 2026-08-01. Headline growth steps down mechanically from the December print, leaving organic growth as the only number with information in it.
• Uniform ratings cut both ways: with 8 Buys and no published Hold or Sell, the aggregate has nowhere to go but down on the first downgrade, and the entire published target band ($20–$25) sits above the tape.

Setup & Price Structure

The $16–18 post-Q1 range that held from June into mid-August broke on the week ending 2026-08-21, which closed at $16.44. That is a weekly close beneath the shelf, not an intraweek probe of it — the distinction matters because the shelf was the structure the accelerating-growth bid had been standing on since the 2026-06-08 print. Distance from the 52-week high of $20.65 is 20.4%. RSI(14) at 26.3 is a genuinely washed-out reading for a name whose last reported quarter grew revenue 49.7%, and the 2.81% gain on 2026-08-21 is the first observable bid against it, though one day is not a base.

Positioning observables, stated without a verdict: the issuer sold equity into strength at $18.00 on 2026-06-30, days after a $19.94 close; three sell-side actions landed in July (07-10 reiteration, 07-22 and 07-24 initiations) at $25 and $22.43-average targets and the stock fell through the following month anyway; average daily volume runs near 1.7M shares against a float enlarged ~14% by the placement; and an earnings binary sits 11 calendar days from the reference close. New attention arriving without a price response is the specific crowding signature here.

The narrative is maturing, at the late edge of it. Dating that — the operating narrative is still producing (revenue +49.7%, 2026-06-08) and coverage expanded rather than contracted after the dilution (initiations 2026-07-22 and 2026-07-24), which is not saturation. But the July attention was fully absorbed by a 20.4% drawdown from the high, which is what thin new bid looks like. A 2026-09-03 print that repeats 23.6% with no deal announced, followed by the first published Hold, would move this to saturated.

Structurally, the next reference beneath the broken shelf is the pre-print zone. Arithmetic on the pipeline's own adjusted series — a three-month price change of +11.0% into the $16.44 close — places the late-May reference in the mid-$14s, so $15.00 sits just above the point where the entire post-Q1 advance would be surrendered.

Catalyst Calendar (next 30 days)

• 2026-09-02 — one-year anniversary of the Crown I close (2025-09-02). From the fiscal quarter that began 2026-08-01, reported and organic growth converge.
• 2026-09-03 — Q2 FY2027 results (quarter ended 2026-07-31), released after the close, call 4:30 p.m. ET. Confirmed by company release 2026-08-20. The binary: gross margin versus 23.6%, and whether any of the ~$94.0M net proceeds has been committed.
• ~2026-09-04 (est.) — first sell-side revisions. With 8 Buys and a $20 published low, the first Hold or a target beneath $20 would be the first break in unanimity since coverage expanded.
• ~2026-09-08 (est.) — Form 10-Q for the quarter ended 2026-07-31, confirming the post-offering cash line, debt and diluted share count the accretion math runs on.

What Would Change Our Mind

The structure this note was standing on has already gone: the $16–18 shelf was lost on the week ending 2026-08-21 at $16.44, which is why conviction on a fresh look at this price is low rather than moderate. What breaks the remainder of the case is the pre-print zone going with it — a weekly close below $15.00 would erase the entire advance built off the 2026-06-08 revenue-acceleration print and leave the name trading as a diluted microcap with an unspent balance sheet.

On the fundamentals, two dated outcomes would break specific legs. A 2026-09-03 gross margin at or below 23.6% with management repeating the packaging-startup framing turns a transient-cost story into a structural one. And a 10-Q around 2026-09-08 still showing essentially the full ~$94.0M in cash, with no announced transaction, means the ~14% share-count increase bought nothing for a full quarter — at which point the roll-up leg is a promise with a two-month-old expiry.

The inverse also matters for grading: a 2026-09-03 print with gross margin back above 25% and a named acquisition would restore both halves of the case at once, and the $16–18 range would become the level to watch from below.

Correlation Notes

This is not an AI or rate-narrative vehicle; it trades with small-cap risk appetite and with grocery-channel input costs. The relevant co-movements are the Russell 2000 (a $764.42M market value with ~1.7M average daily volume moves with microcap flow regardless of company news), fresh-protein and labor costs (beef and poultry feed directly into the 23.6% gross margin the story hinges on), and the reported results of its named growth accounts — Costco, Walmart, Target and Food Lion were the customers cited on the 2026-06-08 call, and the 2026-08-03 Nasdaq opening-bell release put distribution at over 12,000 grocery, mass, club and convenience stores. Peer prepared-foods and deli manufacturers are the closest read-across; a margin warning from any of them ahead of 2026-09-03 would land on this name before its own print does.